about
Peroxiredoxin-4 interacts with and regulates the thromboxane A(2) receptorCarbocations in the synthesis of prostaglandins by the cyclooxygenase of PGH synthase? A radical departure!Antioxidants and coronary artery disease: from pathophysiology to preventive therapyOxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approachesAntihypertensive effects of the flavonoid quercetin in spontaneously hypertensive ratsRaised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseasesGeneration of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanismSerum 8,12-iso-iPF2α-VI isoprostane marker of oxidative damage and cognition deficits in children with konzoMechanisms of noise-induced hearing loss indicate multiple methods of prevention.Reconstruction of cyclooxygenase evolution in animals suggests variable, lineage-specific duplications, and homologs with low sequence identity.Lipid peroxide and hydrogen peroxide formation in parenteral nutrition solutions containing multivitamins.Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss.LDL particle size: an important drug target?The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosisGM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection.Oxyradicals and DNA damage.Multimarker screening of oxidative stress in aging.High-fat meals rich in EPA plus DHA compared with DHA only have differential effects on postprandial lipemia and plasma 8-isoprostane F2α concentrations relative to a control high-oleic acid meal: a randomized controlled trialLower serum levels of selenium, copper, and zinc are related to neuromotor impairments in children with konzo.Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems.Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in miceBiomarkers in exhaled breath condensate: a review of collection, processing and analysis.The Environmental Genome Project: functional analysis of polymorphisms.Effects of some isoprostanes on the human umbilical artery in vitro.Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.F2-isoprostanes and adiposity in older adults.Thioredoxin 1 overexpression extends mainly the earlier part of life span in mice.Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitroCoronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha.Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded RatsOxidative stress and cellular stress response in diabetic nephropathy.Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse modelChanges in Inflammation, Oxidative Stress, Mitochondrial DNA Content after Rosiglitazone in HIV Lipoatrophy.Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urinePaleolithic and Mediterranean Diet Pattern Scores Are Inversely Associated with Biomarkers of Inflammation and Oxidative Balance in Adults.Placental anti-oxidant gene polymorphisms, enzyme activity, and oxidative stress in preeclampsiaAn eicosanoid-centric view of atherothrombotic risk factorsExhaled breath condensate in patients with asthma: implications for application in clinical practice.Patients with microvascular obstruction after primary percutaneous coronary intervention show a gp91phox (NOX2) mediated persistent oxidative stress after reperfusion.Effects of taxifolin on the activity of angiotensin-converting enzyme and reactive oxygen and nitrogen species in the aorta of aging rats and rats treated with the nitric oxide synthase inhibitor and dexamethasone.
P2860
Q24321647-106CBF41-7A91-4431-8A27-EBF39040EC45Q24672649-C0A0D109-3E7E-4320-A9CC-D2C349BA137CQ27025669-2A5ACE51-EECE-424A-96E9-2F0B760B8FDEQ28075691-6875ECC1-949E-45B3-A291-E5D60DA6845DQ28363825-F5BD2849-781B-4F51-9286-EF3C3F071EFEQ28364861-12486DB5-7E56-4960-A3A2-BBC6FCFBCE9EQ28367863-E2A04EE4-BDC0-4708-B7BE-DB39656AFAFEQ28542971-9896B63B-C949-44C9-B1BC-244A64693312Q30500834-2A79A9C8-4DA5-4EAB-8AB1-E0D1F8F1488AQ30908324-F7BADF89-4BC9-4B3F-B2D2-F8858DF758F3Q31975094-F0CDB9C6-BBB8-4209-B886-A4CEC76FE973Q33585814-08B972B8-9D0B-4351-B0AB-CB00C9071BC5Q33693960-B08DC9E7-D233-4323-AFAE-4FAC22DB57D3Q33835675-4B39209F-FA3F-428D-BF18-92106A427991Q33842816-4F65E707-04C9-490B-8CF9-F34096586740Q33846171-5509A2BD-E756-4712-A307-E8FFFC3E9ED3Q34014251-B52C8006-6A21-4BD7-91ED-6E539B80381EQ34179555-6E19255B-9A19-43DD-A4E9-DE7FF45C2EDFQ34458381-7411A849-B884-437F-ADE8-0684E851C961Q34556407-FFAF869F-89AB-4954-9452-2532809F1A09Q34605967-73A5A146-6C3D-4AB8-85D3-670AC9DF5280Q34684120-77EA3F70-3304-4FA5-BB45-1BC4EE7745D0Q34938485-6BF5434F-125F-4048-BD4C-C5FB64F84AD6Q35041898-F286DDC1-09F0-49AD-BA0B-BF0F7554D56CQ35139747-FB7F05D4-C544-4587-A3F8-D4FFE3056EDEQ35381936-2B6C162D-67C1-444B-AE24-7AB71C1FC4F7Q35535899-DA6E1694-ABEA-4E92-B628-17ED90CC37E1Q35635108-C8EE4BC7-84CD-40EA-B884-37798E414644Q35884706-32FF4325-E203-4A2D-8367-E3C190F5C38EQ36080315-29510D9F-477A-4327-BEE3-890D028D8890Q36259336-F5687DFB-AD96-49B5-AB98-1314DF07D536Q36300619-F7470227-06FB-4B8C-9ABD-C8B4A8C56E0AQ36447515-4E374888-DFB6-4965-A036-2F25D369F99AQ36674399-194D6231-B955-4BF3-8EFB-42BE5CDBB431Q36928606-587D1AAA-EACC-4099-9789-9A98FFB1266EQ36942988-90B35285-AA9F-45CF-9797-3CD65E042E33Q36952174-8912054F-6245-4379-9D1B-A71D4318FDBAQ37114066-CD1FD692-54A0-4F67-B7BE-829B9EEDA18BQ37291936-3021417D-2EF3-4F44-9C3E-BCC251F34AB2Q37300636-C92315B2-CCA1-48B8-B293-2024601DC45E
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The isoprostanes
@ast
The isoprostanes
@en
type
label
The isoprostanes
@ast
The isoprostanes
@en
prefLabel
The isoprostanes
@ast
The isoprostanes
@en
P3181
P1476
The isoprostanes
@en
P2093
Jason D. Morrow
L.Jackson Roberts
P3181
P356
10.1016/0006-2952(95)02072-1
P407
P577
1996-01-01T00:00:00Z